Filing Details
- Accession Number:
- 0001209191-12-054291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-21 15:31:42
- Reporting Period:
- 2012-11-19
- Filing Date:
- 2012-11-21
- Accepted Time:
- 2012-11-21 15:31:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1422995 | J. Markus Cappel | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Bus. Officer & Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-19 | 7 | $0.60 | 75,007 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-19 | 7 | $12.10 | 75,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2012-11-20 | 3 | $0.60 | 75,003 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-11-20 | 3 | $12.10 | 75,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-11-19 | 7 | $0.00 | 7 | $0.60 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2012-11-20 | 3 | $0.00 | 3 | $0.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
47,789 | 2014-05-13 | No | 4 | M | Direct | |
47,786 | 2014-05-13 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- As of November 19, 2012 and prior to this transaction, the option fully vested.
- Not applicable.